Kanya Rajangam
Board Member
Senti Biosciences Holdings, Inc. (SNTI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-01-01–present
-
Nkarta, Inc. (NKTX)
Proxy statement
Start not stated–2022-06-05
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
NKTX
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Senti Biosciences Holdings, Inc. (SNTI) | M.D., Ph.D. President, Head of Research and Development and Chief Medical Officer | $526,789 | $627,707 |
| 2023 | Senti Biosciences Holdings, Inc. (SNTI) | M.D., Ph.D. President, Head of Research and Development and Chief Medical Officer | $516,460 | $858,770 |
| 2022 | Senti Biosciences Holdings, Inc. (SNTI) | M.D., Ph.D. President, Head of Research and Development and Chief Medical Officer | $241,288 | $840,506 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.